<DOC>
	<DOCNO>NCT01709240</DOCNO>
	<brief_summary>The purpose study assess safety performance BioWeld1 System procedure surgical incision closure skin woman schedule elective C-section procedure .</brief_summary>
	<brief_title>Evaluation BioWeld1 System Method Surgical Incision Closure</brief_title>
	<detailed_description>In every surgical procedure , need close incision make . Current method incision closure include stitching , glue stapling . Some method time consuming , potential infection may leave significant scar . The bioWeld1 technology suggest new approach incision closure . It novel medical device consist Chitosan film BioWeld1 plasma eject device . The Chitosan film intend apply skin incision , BioWeld1device use weld Chitosan skin mean cold plasma technology .</detailed_description>
	<criteria>1 . Age 20 40 year old . 2 . Women schedule child delivery use elective C section . 3 . Women first second pregnancy Csection first time 4 . Healthy woman systemic disease diabetes , heart disease etc . 5 . Women average weight , BMI prior pregnancy 18.525 . 6 . Women skin diseases 7 . Subject understands study requirement treatment procedure provide write Informed Consent studyspecific test procedure perform . 8 . The subject commits return schedule postoperative followup visit clinic General 1 . Women intend abdominal surgery Csection procedure 2 . Women intend Csection procedure purpose child delivery 3 . Any prior Csection procedure purpose 4 . Women Received/Receiving radiotherapy chemotherapy kind . 5 . Women receive steroid medication interfere wound heal . 6 . Women receive Acutan last half year . 7 . Women bleed diathesis hypercoagulable state . 8 . Women prior cosmetic medical treatment target area ( e.g . phosphatydilcholine injection ) . 9 . Women suffer Thrombocytopenia ( platelet count &lt; 100,000/mm3 ) preprocedure . 10 . Women currently participate participate investigational study , study , within past 60 day . 11 . Psychiatric background . Intra operative exclusion criterion : 1 . Severe excessive bleeding wind 2 . Patient eligible experimental closure accord physician discretion .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Chitosan</keyword>
	<keyword>Plasma</keyword>
	<keyword>Incision Closure</keyword>
</DOC>